NCT00238433 2017-09-27Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's LymphomaOHSU Knight Cancer InstitutePhase 2 Completed37 enrolled 8 charts